Bain Capital Life Sciences Opportunities IV, L.P.

Overview

• HeadquartersBoston, United States²
• Legal formLimited Partnership - Series²
• Kind of organizationLimited partnership²
• LEI25490035FB589UYX5M06²
• StatusActive²
• LEI statusIssued and current²
• Registered addressC/O MAPLES FIDUCIARY SERVICES (DELAWARE) INC., 19807 Wilmington, United States²
• Registered withDivision of Corporations, Department of State, 7642560²

See how the biggest companies compare on our leaderboards

Corporate structure

Bain Capital Life Sciences Opportunities IV, L.P. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Timeline

1. Aug 25, 2023Founded Bain Capital Life Sciences Opportunities IV, L.P. is founded²

Filings

4 filings to the SEC since October 2021: 4 other. The latest 4:

1. Aug 31, 2026N-PX EDGAR
2. Aug 14, 202613F-NT EDGAR
3. May 15, 202613F-NT EDGAR
4. Feb 17, 202613F-NT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Bain Capital Life Sciences Opportunities IV, L.P. has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• Olema Pharmaceuticals, Inc.SCHEDULE 13G/A Dec 11, 2024 to May 15, 2026³